INNOVIVA, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
INNOVIVA, INC. (INVA) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 115.37 million shares for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-24.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2016-02-24
- INNOVIVA, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2015-12-31 was 115.34M shares, a 0.90% increase year-over-year.
- INNOVIVA, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2015-09-30 was 115.79M shares, a 2.38% increase year-over-year.
- INNOVIVA, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2015-06-30 was 115.33M shares, a 3.92% increase year-over-year.
- INNOVIVA, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2015-03-31 was 114.66M shares, a 4.37% increase year-over-year.
- INNOVIVA, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2015 was 115.37M shares, a 2.96% increase from fiscal 2014.
- INNOVIVA, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2014 was 112.06M shares, a 9.41% increase from fiscal 2013.
- INNOVIVA, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2013 was 102.42M shares, a 12.67% increase from fiscal 2012.
- INNOVIVA, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2012 was 90.91M shares, a 10.80% increase from fiscal 2011.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2015-12-31 | 115.34M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | 115.57M shares derived: average of 2 quarters · filed 2016-02-24 | 115.49M shares derived: average of 3 quarters · filed 2016-02-24 | 115.37M shares 10-K · filed 2016-02-24 |
| 2015-09-30 | 115.79M shares 10-Q · filed 2015-11-05 | 115.56M shares derived: average of 2 quarters · filed 2015-11-05 | 115.38M shares 10-Q · filed 2015-11-05 | 115.02M shares derived: average of 4 quarters · filed 2016-02-24 |
| 2015-06-30 | 115.33M shares 10-Q · filed 2015-08-06 | 115.10M shares 10-Q · filed 2015-08-06 | 114.77M shares derived: average of 3 quarters · filed 2016-02-24 | 114.35M shares derived: average of 4 quarters · filed 2016-02-24 |
| 2015-03-31 | 114.66M shares 10-Q · filed 2015-05-08 | 114.49M shares derived: average of 2 quarters · filed 2016-02-24 | 114.03M shares derived: average of 3 quarters · filed 2016-02-24 | 113.26M shares derived: average of 4 quarters · filed 2016-02-24 |
| 2014-12-31 | 114.32M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | 113.71M shares derived: average of 2 quarters · filed 2016-02-24 | 112.80M shares derived: average of 3 quarters · filed 2016-02-24 | 112.06M shares 10-K · filed 2016-02-24 |
| 2014-09-30 | 113.10M shares 10-Q · filed 2015-11-05 | 112.04M shares derived: average of 2 quarters · filed 2015-11-05 | 111.31M shares 10-Q · filed 2015-11-05 | 110.67M shares derived: average of 4 quarters · filed 2016-02-24 |
| 2014-06-30 | 110.97M shares 10-Q · filed 2015-08-06 | 110.42M shares 10-Q · filed 2015-08-06 | 109.86M shares derived: average of 3 quarters · filed 2016-02-24 | 109.12M shares derived: average of 4 quarters · filed 2016-02-24 |
| 2014-03-31 | 109.86M shares 10-Q · filed 2015-05-08 | 109.30M shares derived: average of 2 quarters · filed 2016-02-24 | 108.51M shares derived: average of 3 quarters · filed 2016-02-24 | 105.78M shares derived: average of 4 quarters · filed 2016-02-24 |
| 2013-12-31 | 108.74M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | 107.83M shares derived: average of 2 quarters · filed 2016-02-24 | 104.42M shares derived: average of 3 quarters · filed 2016-02-24 | 102.42M shares 10-K · filed 2016-02-24 |
| 2013-09-30 | 106.92M shares 10-Q · filed 2014-11-04 | 102.26M shares derived: average of 2 quarters · filed 2014-11-04 | 100.32M shares 10-Q · filed 2014-11-04 | |
| 2013-06-30 | 97.60M shares 10-Q · filed 2014-08-07 | 96.96M shares 10-Q · filed 2014-08-07 | ||
| 2013-03-31 | 96.38M shares 10-Q · filed 2014-05-07 | |||
| 2012-12-31 | 90.91M shares 10-K · filed 2015-02-27 | |||
| 2011-12-31 | 82.05M shares 10-K · filed 2014-03-03 | |||
| 2010-12-31 | 72.07M shares 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |